. | . |
From Antarctica to space: telemedicine at the limit by Staff Writers Paris (ESA) Jan 31, 2020
ESA is working with Argentina to test telemedicine device Tempus Pro in the harsh conditions of Antarctica as Europe prepares for its next phase of human exploration in space. The development of these devices was supported by ESA and it is thought they could be used by astronauts and medical teams during future exploration missions. The testing and validation of Tempus Pro in Argentinian Antarctic bases marks a new era of cooperation between ESA and Argentina - a nation that is already a long-standing partner of ESA in Latin America. ESA telemedicine monitors have been deployed for testing at two of Argentina's Antarctic bases - Belgrano II and Carlini. Belgrano II is located less than 1 300 km from the South Pole, with temperatures that can drop below -35oC over summer. Isolated, and built on rocky outcrops, it is seen as a good analogue for missions to the Moon and Mars. Carlini is located at South Coast Potter Cove, on King George Island. Being less isolated than Belgrano II, it will allow teams to compare two different, but extreme, environments.
Tempus Pro in action The device also allows geolocation and voice communications between rescue teams and receivers and is regularly used by civilians and military personnel around the world to measure and transmit life parameters such as a patient's heartrate, blood pressure, respiration rate and temperature to medical doctors. The harsh environment of Antarctica will provide the ultimate viability test.
Connecting in harsh conditions Victor and Daniel believe the strength of Tempus Pro lies in the way the device combines all medical techniques needed to carry out an initial medical assessment in a single, robust unit, as well as its flexibility to transmit information via a range of voice and data networks. Non-medical users can also operate the units thanks to detailed instructions on screen. In Antarctica, there are few reliable options for data transmission. In addition to their own base transmission systems, operators will use an antenna to connect Tempus Pro to the Iridium satellite network that orbits Earth. These satellites will then retransmit the medical data to a receiver in a different location. Made up of 66 cross-linked satellites in Low-Earth Orbit, the Iridium network enables global coverage even when traditional systems are unavailable and will allow users in Antarctica to communicate, by voice in addition to sending data, with the medical team at EAC as well as Dr Juan Manuel Cuiuli and colleagues from the Joint Antarctic Command in Buenos Aires, Argentina.
Spotlight on simulation The devices will be used by researchers as well as by the medical officer of the bases for everyday medical purposes while the technology is evaluated for potential use during space missions.
Device development "The fact that ESA's medical operations team already use this commercially-successful technology for their operations as well space exploration preparatory activities closes the loop nicely," says Arnaud Runge, medical engineer who supervised the technical development of the Tempus Pro. "It demonstrates ESA's ability to support industry in many different areas". Their journey to Antarctica marks the first step in a recent agreement between ESA, the Argentine Antarctic Directorate (DNA) and the National Commission of Space Activities (CONAE). This growing scientific cooperation will include other institutions such as the Catholic University of Argentina, National University of Quilmes and CONICET. It will allow further development of scientific and operational projects in the extreme environment of the Antarctic continent as ESA prepares for further exploration of our solar system. First results of the experiments should be available in the coming weeks and demonstrate how Tempus Pro can be used to medically support a crew of explorers in a situation and environment that most closely resembles what future astronauts will encounter on Mars.
UNC expert helps treat astronaut's blood clot during NASA mission Chapel Hill NC (SPX) Jan 06, 2020 "My first reaction when NASA reached out to me was to ask if I could visit the International Space Station (ISS) to examine the patient myself," said Stephan Moll, MD, UNC School of Medicine blood clot expert and long-time NASA enthusiast. "NASA told me they couldn't get me up to space quickly enough, so I proceeded with the evaluation and treatment process from here in Chapel Hill." Moll was the only non-NASA physician NASA consulted when it was discovered that an astronaut aboard the ISS had a d ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |